European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- High Quality -

The European Pharmacopoeia (Ph. Eur.) is a publication that sets standards for the quality, purity, and strength of medicines in Europe. One of its key monographs is dedicated to tablets, a widely used dosage form for administering active pharmaceutical ingredients (APIs). In this article, we will focus on the Ph. Eur. monograph for tablets, specifically the one designated as "Tablets -0478-".

Intended to be dissolved or dispersed in water before administration; must disintegrate within 5 minutes.

The European Pharmacopoeia is a publication that contains a set of standards for the quality, purity, and strength of medicines. It is published by the European Directorate for the Quality of Medicines & Healthcare (EDQM), which is a department of the Council of Europe. The Ph. Eur. is recognized as a standard for the quality of medicines in Europe, and its monographs are used by regulatory authorities, manufacturers, and control laboratories to ensure the quality of medicines. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

“But manufacturing variability,” countered Luis, the production lead, “could spike scrap rates for legacy lines. Some suppliers can’t guarantee tighter granulation control without capital investment.”

| Issue | Guidance | |-------|----------| | | Use a balance with appropriate precision (≥ 0.1 mg for < 50 mg tablets). | | Coated tablet friability | Not required by 0478, but may be requested by regulators if coating chips. | | Disintegration vs dissolution | Disintegration does not guarantee dissolution; dissolution is the definitive performance test. | | Uniformity of dosage units – mass variation eligibility | Check if active ingredient is ≥ 90% of core mass; otherwise, content uniformity is mandatory. | | Sugar-coated tablets disintegration | Time starts when tablet is placed in apparatus; coating must rupture within a few minutes. | The European Pharmacopoeia (Ph

Compliance with the Ph. Eur. monograph for tablets (0478) is essential for manufacturers who want to market their products in Europe. Regulatory authorities, such as the European Medicines Agency (EMA), require manufacturers to demonstrate that their products meet the requirements of the Ph. Eur. monograph.

More recent updates continued this evolution. Ph. Eur. Supplement 10.6, adopted by the Ph. Eur. Commission in November 2020, included further revisions to the general chapter . In this article, we will focus on the Ph

The European Pharmacopoeia (Ph. Eur.) is a publication that sets out the official standards for the quality, purity, and strength of medicines in Europe. One of the key monographs in the Ph. Eur. is the one for tablets, which is identified by the code "0478". In this article, we will provide an in-depth look at the Ph. Eur. monograph for tablets, its significance, and the requirements that manufacturers must meet to ensure the quality of their tablet products.